{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:36:01Z","timestamp":1768293361669,"version":"3.49.0"},"publisher-location":"Berlin, Heidelberg","reference-count":90,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642380068","type":"print"},{"value":"9783642380075","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T00:00:00Z","timestamp":1381449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T00:00:00Z","timestamp":1381449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-3-642-38007-5_21","type":"book-chapter","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T17:20:06Z","timestamp":1381512006000},"page":"355-376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["New Perspective for an Old Antidiabetic Drug: Metformin as Anticancer Agent"],"prefix":"10.1007","author":[{"given":"Alessandra","family":"Leone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Di Gennaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Bruzzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Avallone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Budillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,11]]},"reference":[{"key":"21_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pharmthera.2011.09.004","volume":"133","author":"A Aljada","year":"2012","unstructured":"Aljada A, Mousa SA (2012) Metformin and neoplasia: implications and indications. Pharmacol Ther 133:108\u2013115","journal-title":"Pharmacol Ther"},{"key":"21_CR2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/sj.bjc.6605846","volume":"103","author":"Y Baba","year":"2010","unstructured":"Baba Y, Nosho K, Shima K et al (2010) Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3\/1 in colorectal cancer. Br J Cancer 103:1025\u20131033","journal-title":"Br J Cancer"},{"key":"21_CR3","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.metabol.2010.09.012","volume":"60","author":"DM Baur","year":"2011","unstructured":"Baur DM, Klotsche J, Hamnvik OP et al (2011) Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort. Metabolism 60:1363\u20131371","journal-title":"Metabolism"},{"key":"21_CR4","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/cncr.26439","volume":"118","author":"S Bayraktar","year":"2012","unstructured":"Bayraktar S, Hernadez-Aya LF, Lei X et al (2012) Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer. Cancer 118:1202\u20131211","journal-title":"Cancer"},{"key":"21_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1158\/1940-6207.CAPR-12-0026","volume":"5","author":"F Bednar","year":"2012","unstructured":"Bednar F, Simeone DM (2012) Metformin and cancer stem cells: old drug, new targets. Cancer Prev Res (Phila) 5:351\u2013354","journal-title":"Cancer Prev Res (Phila)"},{"key":"21_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10911-008-9099-z","volume":"13","author":"A Belfiore","year":"2008","unstructured":"Belfiore A, Frasca F (2008) IGF and insulin receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 13:381\u2013406","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"21_CR7","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1158\/1535-7163.MCT-09-1186","volume":"9","author":"I Ben Sahra","year":"2010","unstructured":"Ben Sahra I, Le Marchand-Brustel Y, Tanti JF et al (2010) Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther 9:1092\u20131099","journal-title":"Mol Cancer Ther"},{"key":"21_CR8","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1158\/0008-5472.CAN-10-1769","volume":"71","author":"I Ben Sahra","year":"2011","unstructured":"Ben Sahra I, Regazzetti C, Robert G et al (2011) Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. Cancer Res 71:4366\u20134372","journal-title":"Cancer Res"},{"key":"21_CR9","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.18632\/oncotarget.432","volume":"2","author":"MV Blagosklonny","year":"2011","unstructured":"Blagosklonny MV (2011) NCI\u2019s provocative questions on cancer: some answers to ignite discussion. Oncotarget 2:1352\u20131367","journal-title":"Oncotarget"},{"issue":"21","key":"21_CR10","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1200\/JCO.2011.39.3769","volume":"30","author":"B Bonanni","year":"2012","unstructured":"Bonanni B, Puntoni M, Cazzaniga M et al (2012) Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial. J Clin Oncol 30(21):2593\u20132600","journal-title":"J Clin Oncol"},{"key":"21_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.2337\/diacare.29.02.06.dc05-1558","volume":"29","author":"SL Bowker","year":"2006","unstructured":"Bowker SL, Majumdar SR, Veugelers P et al (2006) Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 29:254\u2013258","journal-title":"Diabetes Care"},{"key":"21_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ceb.2007.02.003","volume":"19","author":"MC Brahimi-Horn","year":"2007","unstructured":"Brahimi-Horn MC, Chiche J, Pouyssegur J (2007) Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol 19:223\u2013229","journal-title":"Curr Opin Cell Biol"},{"key":"21_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1158\/0008-5472.CAN-09-2257","volume":"70","author":"KA Brown","year":"2010","unstructured":"Brown KA, Simpson ER (2010) Obesity and breast cancer: progress to understanding the relationship. Cancer Res 70:4\u20137","journal-title":"Cancer Res"},{"key":"21_CR14","doi-asserted-by":"publisher","first-page":"6745","DOI":"10.1158\/0008-5472.CAN-06-4447","volume":"67","author":"M Buzzai","year":"2007","unstructured":"Buzzai M, Jones RG, Amaravadi RK et al (2007) Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res 67:6745\u20136752","journal-title":"Cancer Res"},{"key":"21_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1053\/j.gastro.2007.10.040","volume":"134","author":"ST Chari","year":"2008","unstructured":"Chari ST, Leibson CL, Rabe KG et al (2008) Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134:95\u2013101","journal-title":"Gastroenterology"},{"key":"21_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S1726-4901(09)70195-9","volume":"69","author":"HF Chen","year":"2006","unstructured":"Chen HF, Li CY, Chen P et al (2006) Seroprevalence of hepatitis B and C in type 2 diabetic patients. J Chin Med Assoc 69:146\u2013152","journal-title":"J Chin Med Assoc"},{"key":"21_CR17","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1200\/JCO.20.4.1128","volume":"20","author":"RT Chlebowski","year":"2002","unstructured":"Chlebowski RT, Aiello E, McTiernan A (2002) Weight loss in breast cancer patient management. J Clin Oncol 20:1128\u20131143","journal-title":"J Clin Oncol"},{"key":"21_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/gut.2004.052167","volume":"54","author":"JA Davila","year":"2005","unstructured":"Davila JA, Morgan RO, Shaib Y et al (2005) Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 54:533\u2013539","journal-title":"Gut"},{"key":"21_CR19","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","volume":"3","author":"A Decensi","year":"2010","unstructured":"Decensi A, Puntoni M, Goodwin P et al (2010) Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila) 3:1451\u20131461","journal-title":"Cancer Prev Res (Phila)"},{"key":"21_CR20","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1530\/JME-12-0007","volume":"48","author":"RJ Dowling","year":"2012","unstructured":"Dowling RJ, Niraula S, Stambolic V et al (2012) Metformin in cancer: translational challenges. J Mol Endocrinol 48:R31\u2013R43","journal-title":"J Mol Endocrinol"},{"key":"21_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1074\/jbc.275.1.223","volume":"275","author":"MY El-Mir","year":"2000","unstructured":"El-Mir MY, Nogueira V, Fontaine E et al (2000) Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 275:223\u2013228","journal-title":"J Biol Chem"},{"key":"21_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cgh.2005.12.007","volume":"4","author":"HB El-Serag","year":"2006","unstructured":"El-Serag HB, Hampel H, Javadi F (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4:369\u2013380","journal-title":"Clin Gastroenterol Hepatol"},{"key":"21_CR23","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","volume":"330","author":"JM Evans","year":"2005","unstructured":"Evans JM, Donnelly LA, Emslie-Smith AM et al (2005) Metformin and reduced risk of cancer in diabetic patients. BMJ 330:1304\u20131305","journal-title":"BMJ"},{"key":"21_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1158\/0008-5472.CAN-09-2465","volume":"70","author":"M Galli","year":"2010","unstructured":"Galli M, Van Gool F, Rongvaux A et al (2010) The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer. Cancer Res 70:8\u201311","journal-title":"Cancer Res"},{"key":"21_CR25","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4:891\u2013899","journal-title":"Nat Rev Cancer"},{"key":"21_CR26","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1158\/1078-0432.CCR-09-1805","volume":"16","author":"AM Gonzalez-Angulo","year":"2010","unstructured":"Gonzalez-Angulo AM, Meric-Bernstam F (2010) Metformin: a therapeutic opportunity in breast cancer. Clin Cancer Res 16:1695\u20131700","journal-title":"Clin Cancer Res"},{"key":"21_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1200\/JCO.2011.36.2723","volume":"30","author":"PJ Goodwin","year":"2012","unstructured":"Goodwin PJ, Ennis M, Pritchard KI et al (2012) Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. J Clin Oncol 30:164\u2013171","journal-title":"J Clin Oncol"},{"key":"21_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10549-010-1224-1","volume":"126","author":"PJ Goodwin","year":"2011","unstructured":"Goodwin PJ, Stambolic V, Lemieux J et al (2011) Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents. Breast Cancer Res Treat 126:215\u2013220","journal-title":"Breast Cancer Res Treat"},{"key":"21_CR29","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn DM, Shackelford DB, Egan DF et al (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30:214\u2013226","journal-title":"Mol Cell"},{"key":"21_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10549-011-1612-1","volume":"128","author":"S Hadad","year":"2011","unstructured":"Hadad S, Iwamoto T, Jordan L et al (2011) Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial. Breast Cancer Res Treat 128:783\u2013794","journal-title":"Breast Cancer Res Treat"},{"key":"21_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie DG, Ross FA, Hawley SA (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13:251\u2013262","journal-title":"Nat Rev Mol Cell Biol"},{"key":"21_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1471-2407-12-118","volume":"12","author":"T Higurashi","year":"2012","unstructured":"Higurashi T, Takahashi H, Endo H et al (2012) Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial. BMC Cancer 12:118","journal-title":"BMC Cancer"},{"key":"21_CR33","doi-asserted-by":"publisher","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","volume":"69","author":"HA Hirsch","year":"2009","unstructured":"Hirsch HA, Iliopoulos D, Tsichlis PN et al (2009) Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 69:7507\u20137511","journal-title":"Cancer Res"},{"key":"21_CR34","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1074\/jbc.M506850200","volume":"281","author":"S Horman","year":"2006","unstructured":"Horman S, Vertommen D, Heath R et al (2006) Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485\/491. J Biol Chem 281:5335\u20135340","journal-title":"J Biol Chem"},{"key":"21_CR35","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1158\/1940-6207.CAPR-10-0186","volume":"3","author":"K Hosono","year":"2010","unstructured":"Hosono K, Endo H, Takahashi H et al (2010) Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial. Cancer Prev Res (Phila) 3:1077\u20131083","journal-title":"Cancer Prev Res (Phila)"},{"key":"21_CR36","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1002\/ijc.24623","volume":"125","author":"C Hoyo","year":"2009","unstructured":"Hoyo C, Schildkraut JM, Murphy SK et al (2009) IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas. Int J Cancer 125:2673\u20132678","journal-title":"Int J Cancer"},{"key":"21_CR37","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","volume":"92","author":"R Huxley","year":"2005","unstructured":"Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A et al (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92:2076\u20132083","journal-title":"Br J Cancer"},{"key":"21_CR38","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1158\/0008-5472.CAN-10-3471","volume":"71","author":"D Iliopoulos","year":"2011","unstructured":"Iliopoulos D, Hirsch HA, Struhl K (2011) Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types. Cancer Res 71:3196\u20133201","journal-title":"Cancer Res"},{"key":"21_CR39","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1016\/j.ejca.2010.06.012","volume":"46","author":"M Jalving","year":"2010","unstructured":"Jalving M, Gietema JA, Lefrandt JD et al (2010) Metformin: taking away the candy for cancer? Eur J Cancer 46:2369\u20132380","journal-title":"Eur J Cancer"},{"key":"21_CR40","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nature06030","volume":"448","author":"H Ji","year":"2007","unstructured":"Ji H, Ramsey MR, Hayes DN et al (2007) LKB1 modulates lung cancer differentiation and metastasis. Nature 448:807\u2013810","journal-title":"Nature"},{"key":"21_CR41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s11095-008-9770-5","volume":"26","author":"HE Jin","year":"2009","unstructured":"Jin HE, Hong SS, Choi MK et al (2009) Reduced antidiabetic effect of metformin and down-regulation of hepatic Oct1 in rats with ethynylestradiol-induced cholestasis. Pharm Res 26:549\u2013559","journal-title":"Pharm Res"},{"key":"21_CR42","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1200\/JCO.2009.19.6410","volume":"27","author":"S Jiralerspong","year":"2009","unstructured":"Jiralerspong S, Palla SL, Giordano SH et al (2009) Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 27:3297\u20133302","journal-title":"J Clin Oncol"},{"key":"21_CR43","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","volume":"11","author":"A Kalender","year":"2010","unstructured":"Kalender A, Selvaraj A, Kim SY et al (2010) Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab 11:390\u2013401","journal-title":"Cell Metab"},{"key":"21_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","volume":"3","author":"JW Kim","year":"2006","unstructured":"Kim JW, Tchernyshyov I, Semenza GL et al (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3:177\u2013185","journal-title":"Cell Metab"},{"key":"21_CR45","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1158\/0008-5472.CAN-11-3870","volume":"72","author":"YH Kim","year":"2012","unstructured":"Kim YH, Liang H, Liu X et al (2012) AMPKalpha modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer. Cancer Res 72:2512\u20132521","journal-title":"Cancer Res"},{"key":"21_CR46","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.1158\/0008-5472.CAN-09-0418","volume":"69","author":"K Kisfalvi","year":"2009","unstructured":"Kisfalvi K, Eibl G, Sinnett-Smith J et al (2009) Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. Cancer Res 69:6539\u20136545","journal-title":"Cancer Res"},{"key":"21_CR47","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel. Cancer Cell 13:472\u2013482","journal-title":"Cancer Cell"},{"key":"21_CR48","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0899-9007(99)00266-X","volume":"16","author":"FP Kuhajda","year":"2000","unstructured":"Kuhajda FP (2000) Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16:202\u2013208","journal-title":"Nutrition"},{"key":"21_CR49","doi-asserted-by":"publisher","first-page":"322","DOI":"10.2337\/dc09-1380","volume":"33","author":"GW Landman","year":"2010","unstructured":"Landman GW, Kleefstra N, van Hateren KJ et al (2010) Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care 33:322\u2013326","journal-title":"Diabetes Care"},{"key":"21_CR50","doi-asserted-by":"publisher","first-page":"10238","DOI":"10.1158\/0008-5472.CAN-08-2755","volume":"68","author":"JH Law","year":"2008","unstructured":"Law JH, Habibi G, Hu K et al (2008) Phosphorylated insulin-like growth factor-i\/insulin receptor is present in all breast cancer subtypes and is related to poor survival. Cancer Res 68:10238\u201310246","journal-title":"Cancer Res"},{"key":"21_CR51","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI29044","volume":"116","author":"YC Long","year":"2006","unstructured":"Long YC, Zierath JR (2006) AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 116:1776\u20131783","journal-title":"J Clin Invest"},{"key":"21_CR52","doi-asserted-by":"publisher","first-page":"28106","DOI":"10.1074\/jbc.M803508200","volume":"283","author":"CW Lu","year":"2008","unstructured":"Lu CW, Lin SC, Chen KF et al (2008) Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance. J Biol Chem 283:28106\u201328114","journal-title":"J Biol Chem"},{"issue":"21","key":"21_CR53","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1200\/JCO.2012.42.1677","volume":"30","author":"M Martin","year":"2012","unstructured":"Martin M, Marais R (2012) Metformin: a diabetes drug for cancer, or a cancer drug for diabetics? J Clin Oncol 30(21):2698\u20132700","journal-title":"J Clin Oncol"},{"key":"21_CR54","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1158\/2159-8290.CD-11-0280","volume":"2","author":"MJ Martin","year":"2012","unstructured":"Martin MJ, Hayward R, Viros A et al (2012) Metformin accelerates the growth of BRAFV600E-driven melanoma by upregulating VEGF-A. Cancer Discov 2:344\u2013355","journal-title":"Cancer Discov"},{"key":"21_CR55","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/sj.bjc.6605932","volume":"103","author":"P Massoner","year":"2010","unstructured":"Massoner P, Ladurner-Rennau M, Eder IE et al (2010) Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer. Br J Cancer 103:1479\u20131484","journal-title":"Br J Cancer"},{"key":"21_CR56","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/1535-7163.MCT-11-0871","volume":"11","author":"J Matsuo","year":"2012","unstructured":"Matsuo J, Tsukumo Y, Saito S et al (2012) Hyperactivation of 4E-binding protein 1 as a mediator of biguanide-induced cytotoxicity during glucose deprivation. Mol Cancer Ther 11:1082\u20131091","journal-title":"Mol Cancer Ther"},{"key":"21_CR57","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s11912-010-0111-6","volume":"12","author":"PJ Mazzone","year":"2010","unstructured":"Mazzone PJ (2010) Lung cancer screening: an update, discussion, and look ahead. Curr Oncol Rep 12:226\u2013234","journal-title":"Curr Oncol Rep"},{"key":"21_CR58","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1586\/ers.09.68","volume":"4","author":"PJ Mazzone","year":"2010","unstructured":"Mazzone PJ (2010) Preoperative evaluation of the lung cancer resection candidate. Expert Rev Respir Med 4:97\u2013113","journal-title":"Expert Rev Respir Med"},{"key":"21_CR59","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1158\/1940-6207.CAPR-10-0055","volume":"3","author":"RM Memmott","year":"2010","unstructured":"Memmott RM, Mercado JR, Maier CR et al (2010) Metformin prevents tobacco carcinogen\u2013induced lung tumorigenesis. Cancer Prev Res (Phila) 3:1066\u20131076","journal-title":"Cancer Prev Res (Phila)"},{"key":"21_CR60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2337\/dc10-1287","volume":"34","author":"M Monami","year":"2011","unstructured":"Monami M, Colombi C, Balzi D et al (2011) Metformin and cancer occurrence in insulin-treated type 2 diabetic patients. Diabetes Care 34:129\u2013131","journal-title":"Diabetes Care"},{"key":"21_CR61","doi-asserted-by":"publisher","first-page":"e33411","DOI":"10.1371\/journal.pone.0033411","volume":"7","author":"H Noto","year":"2012","unstructured":"Noto H, Goto A, Tsujimoto T et al (2012) Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. PLoS ONE 7:e33411","journal-title":"PLoS ONE"},{"key":"21_CR62","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s10552-012-9971-4","volume":"23","author":"AA Onitilo","year":"2012","unstructured":"Onitilo AA, Engel JM, Glurich I et al (2012) Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. Cancer Causes Control 23:991\u20131008","journal-title":"Cancer Causes Control"},{"issue":"Pt 3","key":"21_CR63","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/0264-6021:3480607","volume":"348","author":"MR Owen","year":"2000","unstructured":"Owen MR, Doran E, Halestrap AP (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348(Pt 3):607\u2013614","journal-title":"Biochem J"},{"key":"21_CR64","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1470-2045(08)70337-1","volume":"10","author":"R Pannala","year":"2009","unstructured":"Pannala R, Basu A, Petersen GM et al (2009) New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 10:88\u201395","journal-title":"Lancet Oncol"},{"key":"21_CR65","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","volume":"3","author":"I Papandreou","year":"2006","unstructured":"Papandreou I, Cairns RA, Fontana L et al (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3:187\u2013197","journal-title":"Cell Metab"},{"key":"21_CR66","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak M (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8:915\u2013928","journal-title":"Nat Rev Cancer"},{"key":"21_CR67","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1158\/1078-0432.CCR-12-0694","volume":"18","author":"M Pollak","year":"2012","unstructured":"Pollak M (2012) Metformin and pancreatic cancer: a clue requiring investigation. Clin Cancer Res 18:2723\u20132725","journal-title":"Clin Cancer Res"},{"key":"21_CR68","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature04871","volume":"441","author":"J Pouyssegur","year":"2006","unstructured":"Pouyssegur J, Dayan F, Mazure NM (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441:437\u2013443","journal-title":"Nature"},{"key":"21_CR69","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1158\/1078-0432.CCR-10-2243","volume":"17","author":"GZ Rocha","year":"2011","unstructured":"Rocha GZ, Dias MM, Ropelle ER et al (2011) Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth. Clin Cancer Res 17:3993\u20134005","journal-title":"Clin Cancer Res"},{"key":"21_CR70","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1158\/1078-0432.CCR-09-2229","volume":"16","author":"E Rozengurt","year":"2010","unstructured":"Rozengurt E, Sinnett-Smith J, Kisfalvi K (2010) Crosstalk between insulin\/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer. Clin Cancer Res 16:2505\u20132511","journal-title":"Clin Cancer Res"},{"key":"21_CR71","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1158\/0008-5472.CAN-08-3722","volume":"69","author":"I Samudio","year":"2009","unstructured":"Samudio I, Fiegl M, Andreeff M (2009) Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. Cancer Res 69:2163\u20132166","journal-title":"Cancer Res"},{"key":"21_CR72","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.bbrc.2011.09.134","volume":"414","author":"ED Segal","year":"2011","unstructured":"Segal ED, Yasmeen A, Beauchamp MC et al (2011) Relevance of the OCT1 transporter to the antineoplastic effect of biguanides. Biochem Biophys Res Commun 414:694\u2013699","journal-title":"Biochem Biophys Res Commun"},{"key":"21_CR73","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1743-7075-7-7","volume":"7","author":"TN Seyfried","year":"2010","unstructured":"Seyfried TN, Shelton LM (2010) Cancer as a metabolic disease. Nutr Metab (Lond) 7:7","journal-title":"Nutr Metab (Lond)"},{"key":"21_CR74","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1172\/JCI30558","volume":"117","author":"Y Shu","year":"2007","unstructured":"Shu Y, Sheardown SA, Brown C et al (2007) Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest 117:1422\u20131431","journal-title":"J Clin Invest"},{"key":"21_CR75","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/srep00362","volume":"2","author":"CW Song","year":"2012","unstructured":"Song CW, Lee H, Dings RP et al (2012) Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells. Sci Rep 2:362","journal-title":"Sci Rep"},{"key":"21_CR76","unstructured":"Stambolic V (2012). A. 2012. Chicago"},{"key":"21_CR77","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10549-008-0015-4","volume":"114","author":"V Stambolic","year":"2009","unstructured":"Stambolic V, Woodgett JR, Fantus IG et al (2009) Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor? Breast Cancer Res Treat 114:387\u2013389","journal-title":"Breast Cancer Res Treat"},{"key":"21_CR78","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1002\/cncr.26151","volume":"117","author":"BX Tan","year":"2011","unstructured":"Tan BX, Yao WX, Ge J et al (2011) Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes. Cancer 117:5103\u20135111","journal-title":"Cancer"},{"key":"21_CR79","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029\u20131033","journal-title":"Science"},{"key":"21_CR80","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1677\/ERC-09-0087","volume":"16","author":"P Vigneri","year":"2009","unstructured":"Vigneri P, Frasca F, Sciacca L et al (2009) Diabetes and cancer. Endocr Relat Cancer 16:1103\u20131123","journal-title":"Endocr Relat Cancer"},{"key":"21_CR81","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1038\/sj.onc.1208463","volume":"24","author":"HQ Wang","year":"2005","unstructured":"Wang HQ, Altomare DA, Skele KL et al (2005) Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells. Oncogene 24:3574\u20133582","journal-title":"Oncogene"},{"key":"21_CR82","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.tcb.2008.01.008","volume":"18","author":"T Williams","year":"2008","unstructured":"Williams T, Brenman JE (2008) LKB1 and AMPK in cell polarity and division. Trends Cell Biol 18:193\u2013198","journal-title":"Trends Cell Biol"},{"key":"21_CR83","doi-asserted-by":"publisher","first-page":"e5137","DOI":"10.1371\/journal.pone.0005137","volume":"4","author":"SN Wingo","year":"2009","unstructured":"Wingo SN, Gallardo TD, Akbay EA et al (2009) Somatic LKB1 mutations promote cervical cancer progression. PLoS ONE 4:e5137","journal-title":"PLoS ONE"},{"key":"21_CR84","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1158\/1078-0432.CCR-09-1955","volume":"16","author":"G Zadra","year":"2010","unstructured":"Zadra G, Priolo C, Patnaik A et al (2010) New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPK. Clin Cancer Res 16:3322\u20133328","journal-title":"Clin Cancer Res"},{"key":"21_CR85","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1158\/1940-6207.CAPR-08-0081","volume":"1","author":"M Zakikhani","year":"2008","unstructured":"Zakikhani M, Dowling RJ, Sonenberg N et al (2008) The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase. Cancer Prev Res (Phila) 1:369\u2013375","journal-title":"Cancer Prev Res (Phila)"},{"key":"21_CR86","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1158\/1078-0432.CCR-09-2719","volume":"16","author":"M Zhang","year":"2010","unstructured":"Zhang M, Hu Z, Huang J et al (2010) A 3\u2019-untranslated region polymorphism in IGF1 predicts survival of non-small cell lung cancer in a Chinese population. Clin Cancer Res 16:1236\u20131244","journal-title":"Clin Cancer Res"},{"key":"21_CR87","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2741\/3826","volume":"16","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, Liu H, Riker AI et al (2011) Emerging metabolic targets in cancer therapy. Front Biosci 16:1844\u20131860","journal-title":"Front Biosci"},{"key":"21_CR88","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.molcel.2008.12.026","volume":"33","author":"B Zheng","year":"2009","unstructured":"Zheng B, Jeong JH, Asara JM et al (2009) Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation. Mol Cell 33:237\u2013247","journal-title":"Mol Cell"},{"key":"21_CR89","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou G, Myers R, Li Y et al (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167\u20131174","journal-title":"J Clin Invest"},{"key":"21_CR90","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1158\/1541-7786.MCR-10-0343","volume":"9","author":"Y Zhuang","year":"2011","unstructured":"Zhuang Y, Miskimins WK (2011) Metformin induces both caspase-dependent and poly(ADP-ribose) polymerase-dependent cell death in breast cancer cells. Mol Cancer Res 9:603\u2013615","journal-title":"Mol Cancer Res"}],"container-title":["Cancer Treatment and Research","Advances in Nutrition and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-38007-5_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T02:23:40Z","timestamp":1676341420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-38007-5_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,11]]},"ISBN":["9783642380068","9783642380075"],"references-count":90,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-38007-5_21","relation":{},"ISSN":["0927-3042"],"issn-type":[{"value":"0927-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10,11]]},"assertion":[{"value":"11 October 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}